» Articles » PMID: 39360098

Injectable Platelet-Rich Fibrin and Hyaluronic Acid Mesotherapy for Management of Actinic Elastosis of Lower Eyelids: A Case Series

Overview
Journal Cureus
Date 2024 Oct 3
PMID 39360098
Authors
Affiliations
Soon will be listed here.
Abstract

Rejuvenating the skin on the lower eyelids is often complicated. Treatment alternatives that have been practiced in the past had several complications. Additionally, they were not completely effective in addressing skin aging or actinic elastosis symptoms such as dark circles under the eyes. A minimally invasive therapy approach that improves the above-mentioned issues in a desirable way has been discussed in this case series. The patients selected were of the age group between 20-40 years who had actinic elastosis of the lower eyelid. The patients were injected twice at one-month intervals with a combination of injectable platelet-rich fibrin (iPRF) and hyaluronic acid. The patients were examined on the day of treatment and one month after the second injection. A progressive improvement in the esthetic outcome and a high level of patient satisfaction were observed. Apart from the predicted visible swelling right away following the iPRF injection. The outcomes have shown that a series of iPRF with hyaluronic acid injections in the lower eyelid region is a safe, proficient, pain-free, simple and rapid treatment option for actinic elastosis.

References
1.
Jones C . Platelet function and ageing. Mamm Genome. 2016; 27(7-8):358-66. PMC: 4935731. DOI: 10.1007/s00335-016-9629-8. View

2.
Cowman J, Dunne E, Oglesby I, Byrne B, Ralph A, Voisin B . Age-related changes in platelet function are more profound in women than in men. Sci Rep. 2015; 5:12235. PMC: 4503960. DOI: 10.1038/srep12235. View

3.
Scharffetter-Kochanek K, Brenneisen P, Wenk J, Herrmann G, Ma W, Kuhr L . Photoaging of the skin from phenotype to mechanisms. Exp Gerontol. 2000; 35(3):307-16. DOI: 10.1016/s0531-5565(00)00098-x. View

4.
Lowe N, Ascher B, Heckmann M, Kumar C, Fraczek S, Eadie N . Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow's feet. Dermatol Surg. 2005; 31(3):257-62. DOI: 10.1111/j.1524-4725.2005.31070. View

5.
Andre P . New trends in face rejuvenation by hyaluronic acid injections. J Cosmet Dermatol. 2009; 7(4):251-8. DOI: 10.1111/j.1473-2165.2008.00402.x. View